102 related articles for article (PubMed ID: 30185019)
1. Ultrasound-Responsive Nanoparticulate for Selective Amplification of Chemotherapeutic Potency for Ablation of Solid Tumors.
Xia J; Wang J; Wang X; Qian M; Zhang L; Chen Q
Bioconjug Chem; 2018 Oct; 29(10):3467-3475. PubMed ID: 30185019
[TBL] [Abstract][Full Text] [Related]
2. Poly(lactobionamidoethyl methacrylate)-based amphiphiles with ultrasound-labile components in manufacture of drug delivery nanoparticulates for augmented cytotoxic efficacy to hepatocellular carcinoma.
Wang J; Xia Y; Liu H; Xia J; Qian M; Zhang L; Chen L; Chen Q
J Colloid Interface Sci; 2019 Sep; 551():1-9. PubMed ID: 31071490
[TBL] [Abstract][Full Text] [Related]
3. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
Kashyap S; Singh N; Surnar B; Jayakannan M
Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
[TBL] [Abstract][Full Text] [Related]
4. Tumor-homing, pH- and ultrasound-responsive polypeptide-doxorubicin nanoconjugates overcome doxorubicin resistance in cancer therapy.
Wang Z; He Q; Zhao W; Luo J; Gao W
J Control Release; 2017 Oct; 264():66-75. PubMed ID: 28837822
[TBL] [Abstract][Full Text] [Related]
5. Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance.
Braunová A; Kostka L; Sivák L; Cuchalová L; Hvězdová Z; Laga R; Filippov S; Černoch P; Pechar M; Janoušková O; Šírová M; Etrych T
J Control Release; 2017 Jan; 245():41-51. PubMed ID: 27871991
[TBL] [Abstract][Full Text] [Related]
6. Biocompatible cationic pullulan-g-desoxycholic acid-g-PEI micelles used to co-deliver drug and gene for cancer therapy.
Chen L; Ji F; Bao Y; Xia J; Guo L; Wang J; Li Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):418-429. PubMed ID: 27770912
[TBL] [Abstract][Full Text] [Related]
7. A small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapy.
Mou Q; Ma Y; Zhu X; Yan D
J Control Release; 2016 May; 230():34-44. PubMed ID: 27040815
[TBL] [Abstract][Full Text] [Related]
8. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery.
Lee JY; Chung SJ; Cho HJ; Kim DD
Eur J Pharm Biopharm; 2015 Aug; 94():532-41. PubMed ID: 26149228
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of doxorubicin in glioblastoma multiforme following ultrasound-Induced blood-brain barrier disruption as determined by microdialysis.
Lin YL; Wu MT; Yang FY
J Pharm Biomed Anal; 2018 Feb; 149():482-487. PubMed ID: 29175555
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery.
Thambi T; Deepagan VG; Yoon HY; Han HS; Kim SH; Son S; Jo DG; Ahn CH; Suh YD; Kim K; Kwon IC; Lee DS; Park JH
Biomaterials; 2014 Feb; 35(5):1735-43. PubMed ID: 24290696
[TBL] [Abstract][Full Text] [Related]
11. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
Sun B; Deng C; Meng F; Zhang J; Zhong Z
Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
[TBL] [Abstract][Full Text] [Related]
12. Disease-directed design of biodegradable polymers: Reactive oxygen species and pH-responsive micellar nanoparticles for anticancer drug delivery.
Leong J; Chin W; Ke X; Gao S; Kong H; Hedrick JL; Yang YY
Nanomedicine; 2018 Nov; 14(8):2666-2677. PubMed ID: 30017961
[TBL] [Abstract][Full Text] [Related]
13. Acid-degradable lactobionic acid-modified soy protein nanogels crosslinked by ortho ester linkage for efficient antitumor in vivo.
Cheng X; Qin J; Wang X; Zha Q; Yao W; Fu S; Tang R
Eur J Pharm Biopharm; 2018 Jul; 128():247-258. PubMed ID: 29730261
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy.
Rapoport N; Gao Z; Kennedy A
J Natl Cancer Inst; 2007 Jul; 99(14):1095-106. PubMed ID: 17623798
[TBL] [Abstract][Full Text] [Related]
15. Tumor-preferential sustained drug release enhances antitumor activity of block copolymer micelles.
Ponta A; Bae Y
J Drug Target; 2014 Aug; 22(7):619-28. PubMed ID: 24766185
[TBL] [Abstract][Full Text] [Related]
16. Design of tumor-homing and pH-responsive polypeptide-doxorubicin nanoparticles with enhanced anticancer efficacy and reduced side effects.
Hu J; Xie L; Zhao W; Sun M; Liu X; Gao W
Chem Commun (Camb); 2015 Jul; 51(57):11405-8. PubMed ID: 26086450
[TBL] [Abstract][Full Text] [Related]
17. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
[TBL] [Abstract][Full Text] [Related]
19. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
[TBL] [Abstract][Full Text] [Related]
20. An ROS-responsive and self-accelerating drug release nanoplatform for overcoming multidrug resistance.
Lv X; Zhu Y; Ghandehari H; Yu A; Wang Y
Chem Commun (Camb); 2019 Mar; 55(23):3383-3386. PubMed ID: 30821310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]